ADVERTISEMENT
Microbial Signatures in Blood Are Associated with Various Cancers
Microbial Signatures in Blood Are Associated with Various Cancers
A study suggests the potential for a noninvasive diagnostic that could detect tumors early and differentiate between disease types.
Microbial Signatures in Blood Are Associated with Various Cancers
Microbial Signatures in Blood Are Associated with Various Cancers

A study suggests the potential for a noninvasive diagnostic that could detect tumors early and differentiate between disease types.

A study suggests the potential for a noninvasive diagnostic that could detect tumors early and differentiate between disease types.

genetics & genomics, biomarkers

diabetes complications type 2 biomarker blood test screen hydroxymethylation epigenetics cytosine
Blood-Based Epigenetic Screen Tests for Diabetes Complications
Katarina Zimmer | Oct 1, 2019 | 4 min read
Researchers could accurately detect life-threatening vascular complications in type 2 diabetes patients by analyzing hydroxymethylated cytosines in freely circulating DNA.
Immune Response to Gut Microbes Linked to Diabetes Risk
Abby Olena, PhD | Feb 1, 2019 | 3 min read
Researchers find that it’s not just high-risk genes, but how children’s bodies respond to their own intestinal microbiota that relates to future diagnoses of type 1 diabetes.
Toward Blood-based Cancer Detection
Jyoti Madhusoodanan | Jul 7, 2015 | 4 min read
Circulating tumor cells, exosomes, and DNA can improve the diagnosis of many cancers. But are liquid biopsies ready for prime time?
The Challenges of Precision
Adam Marcus | Apr 1, 2015 | 3 min read
Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.
A Blood-based Biomarker for Suicide?
Jyoti Madhusoodanan | Jul 31, 2014 | 2 min read
Epigenetic and genetic changes in the SKA2 gene are correlated with suicidal behaviors, researchers show.
Obesity Complicates Colorectal Cancer
Tracy Vence | Apr 9, 2014 | 2 min read
Study finds that prediagnosis obesity is predictive of poor prognosis, even among patients who have a molecular marker associated with better disease outcome.
Week in Review: March 10–14
Tracy Vence | Mar 14, 2014 | 3 min read
Whole-genome sequencing in the clinic; blood-based biomarkers predict future cognitive problems; how some pain meds inhibit bacterial growth; ResearchGate launches Open Review
Decoding DNA: New Twists and Turns
Kerry Grens | Jun 1, 2013 | 10+ min read
Highlights from a series of three webinars on the future of genome research, held by The Scientist to celebrate 60 years of the DNA double helix
ADVERTISEMENT